| Mar 2, 2026 |
Mar 3, 2026 |
Kilroy Conor
|
Officer |
Neutral |
90.0
|
+62,339
|
37.28%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Gibney Anthony S
|
Officer |
Neutral |
90.0
|
+71,245
|
34.43%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
de los Pinos Elisabet
|
Officer |
Neutral |
90.0
|
+166,000
|
30.88%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Plavsic Mark
|
Chief Technology Officer |
Neutral |
90.0
|
+62,339
|
34.37%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Hopkins Janet Jill
|
Chief Medical Officer |
Neutral |
90.0
|
+89,056
|
38.34%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Elazzouzi Amy
|
President |
Neutral |
90.0
|
+44,528
|
58.95%
|
✗
|
- |
| Feb 17, 2026 |
Feb 17, 2026 |
Kilroy Conor
|
Officer |
Sell |
42.5
|
-12,079
|
-6.74%
|
✗
|
$61K |
| Feb 17, 2026 |
Feb 17, 2026 |
Plavsic Mark
|
Chief Technology Officer |
Sell |
42.5
|
-15,890
|
-8.05%
|
✗
|
$80.2K |
| Feb 17, 2026 |
Feb 17, 2026 |
Hopkins Janet Jill
|
Chief Medical Officer |
Sell |
42.5
|
-20,401
|
-8.07%
|
✗
|
$103.2K |
| Feb 17, 2026 |
Feb 17, 2026 |
Elazzouzi Amy
|
President |
Sell |
46.3
|
-8,549
|
-10.17%
|
✗
|
$43.3K |
| Feb 17, 2026 |
Feb 17, 2026 |
de los Pinos Elisabet
|
Officer |
Sell |
42.5
|
-47,648
|
-8.14%
|
✗
|
$241.1K |
| Jan 20, 2026 |
Jan 20, 2026 |
Elazzouzi Amy
|
President |
Sell |
47.5
|
-1,581
|
-1.85%
|
✗
|
$7.7K |
| Jan 20, 2026 |
Jan 20, 2026 |
de los Pinos Elisabet
|
Officer |
Sell |
42.5
|
-16,928
|
-2.81%
|
✗
|
$82.3K |
| Nov 17, 2025 |
Nov 17, 2025 |
Hopkins Janet Jill
|
Chief Medical Officer |
Sell |
42.5
|
-17,109
|
-6.34%
|
✗
|
$92.7K |
| Oct 29, 2025 |
Oct 29, 2025 |
Elazzouzi Amy
|
President |
Sell |
47.5
|
-896
|
-1.04%
|
✗
|
$5.7K |
| Oct 29, 2025 |
Oct 29, 2025 |
de los Pinos Elisabet
|
Officer |
Sell |
42.5
|
-9,049
|
-1.48%
|
✗
|
$57.5K |
| Oct 16, 2025 |
Oct 16, 2025 |
Plavsic Mark
|
Chief Technology Officer |
Sell |
42.5
|
-12,169
|
-5.81%
|
✗
|
$77.3K |
| Aug 18, 2025 |
Aug 18, 2025 |
Elazzouzi Amy
|
President |
Sell |
22.5
|
-7,722
|
-8.19%
|
✗
|
$51.7K |
| Jun 17, 2025 |
Jun 18, 2025 |
Srivastava Sapna
|
Director |
Neutral |
90.0
|
+13,000
|
123.81%
|
✗
|
- |
| Jun 17, 2025 |
Jun 18, 2025 |
Johnson David Michael
|
Director |
Neutral |
82.5
|
+13,000
|
2.85%
|
✗
|
- |
| Jun 17, 2025 |
Jun 18, 2025 |
Mattessich Antony C.
|
Director |
Neutral |
90.0
|
+13,000
|
123.81%
|
✗
|
- |
| Jun 2, 2025 |
Jun 4, 2025 |
Gibney Anthony S
|
Officer |
Neutral |
90.0
|
+150,000
|
263.47%
|
✗
|
- |
| Jun 2, 2025 |
Jun 4, 2025 |
de los Pinos Elisabet
|
Officer |
Sell |
22.5
|
-9,948
|
-1.60%
|
✗
|
$61.3K |
| May 16, 2025 |
May 20, 2025 |
Johnson David Michael
|
Director |
Buy |
87.5
|
+20,000
|
4.59%
|
✗
|
$98K |
| May 16, 2025 |
May 20, 2025 |
Gibney Anthony S
|
Officer |
Buy |
95.0
|
+48,481
|
573.60%
|
✗
|
$237.2K |
|
May 16, 2025 |
Gibney Anthony S
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 16, 2025 |
Apr 16, 2025 |
Elazzouzi Amy
|
President |
Sell |
47.5
|
-897
|
-1.09%
|
✗
|
$4.9K |
| Apr 16, 2025 |
Apr 16, 2025 |
Kilroy Conor
|
Officer |
Sell |
46.3
|
-7,162
|
-3.84%
|
✗
|
$39.3K |
| Mar 31, 2025 |
Apr 2, 2025 |
Bitetti Teresa Marie
|
Director |
Neutral |
90.0
|
+21,000
|
100.00%
|
✗
|
- |
|
Apr 2, 2025 |
Bitetti Teresa Marie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2025 |
Feb 18, 2025 |
Plavsic Mark
|
Chief Technology Officer |
Sell |
46.3
|
-2,151
|
-1.02%
|
✗
|
$16.7K |
| Feb 18, 2025 |
Feb 18, 2025 |
Elazzouzi Amy
|
President |
Sell |
46.3
|
-1,404
|
-1.68%
|
✗
|
$10.9K |
| Feb 18, 2025 |
Feb 18, 2025 |
Hopkins Janet Jill
|
Chief Medical Officer |
Sell |
48.8
|
-2,534
|
-0.93%
|
✗
|
$19.6K |
| Feb 18, 2025 |
Feb 18, 2025 |
de los Pinos Elisabet
|
Officer |
Sell |
42.5
|
-20,221
|
-3.21%
|
✗
|
$156.8K |
| Feb 3, 2025 |
Feb 4, 2025 |
de los Pinos Elisabet
|
Officer |
Neutral |
90.0
|
+194,320
|
44.56%
|
✗
|
- |
| Feb 3, 2025 |
Feb 4, 2025 |
Plavsic Mark
|
Chief Technology Officer |
Neutral |
90.0
|
+90,475
|
74.69%
|
✗
|
- |
| Feb 3, 2025 |
Feb 4, 2025 |
Hopkins Janet Jill
|
Chief Medical Officer |
Neutral |
90.0
|
+120,635
|
79.53%
|
✗
|
- |
| Feb 3, 2025 |
Feb 4, 2025 |
Kilroy Conor
|
Officer |
Neutral |
90.0
|
+90,475
|
94.24%
|
✗
|
- |
| Feb 3, 2025 |
Feb 4, 2025 |
Elazzouzi Amy
|
President |
Neutral |
90.0
|
+45,240
|
117.68%
|
✗
|
- |
| Jan 21, 2025 |
Jan 21, 2025 |
de los Pinos Elisabet
|
Officer |
Sell |
42.5
|
-15,955
|
-3.53%
|
✗
|
$122.4K |
| Jan 21, 2025 |
Jan 21, 2025 |
Elazzouzi Amy
|
President |
Sell |
47.5
|
-1,001
|
-2.54%
|
✗
|
$7.7K |
| Nov 18, 2024 |
Nov 18, 2024 |
Hopkins Janet Jill
|
Chief Medical Officer |
Sell |
42.5
|
-11,822
|
-7.23%
|
✗
|
$110.7K |
| Oct 29, 2024 |
Oct 29, 2024 |
de los Pinos Elisabet
|
Officer |
Sell |
42.5
|
-9,200
|
-1.99%
|
✗
|
$98.8K |
| Oct 29, 2024 |
Oct 29, 2024 |
Elazzouzi Amy
|
President |
Sell |
47.5
|
-553
|
-1.38%
|
✗
|
$5.9K |
|
Oct 29, 2024 |
Elazzouzi Amy
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 18, 2024 |
Oct 21, 2024 |
Feder Julie B
|
CFO |
Sell |
17.5
|
-25,131
|
-15.77%
|
✓
|
$302.4K |
| Oct 18, 2024 |
Oct 18, 2024 |
de los Pinos Elisabet
|
Officer |
Sell |
30.0
|
-24,992
|
-5.14%
|
✓
|
$300.8K |
| Oct 16, 2024 |
Oct 16, 2024 |
Plavsic Mark
|
Chief Technology Officer |
Sell |
42.5
|
-7,383
|
-5.74%
|
✗
|
$72.7K |
| Sep 27, 2024 |
Oct 1, 2024 |
de los Pinos Elisabet
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Mattessich Antony C.
|
Director |
Neutral |
90.0
|
+10,500
|
100.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Srivastava Sapna
|
Director |
Neutral |
90.0
|
+10,500
|
100.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Johnson David Michael
|
Director |
Neutral |
77.5
|
+10,500
|
2.47%
|
✗
|
- |
| Apr 2, 2024 |
Apr 4, 2024 |
Kilroy Conor
|
General Counsel and Secretary |
Neutral |
90.0
|
+96,000
|
100.00%
|
✗
|
- |
|
Apr 4, 2024 |
Kilroy Conor
|
General Counsel and Secretary |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 25, 2024 |
Plavsic Mark
|
Chief Technology Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 2, 2024 |
Hopkins Janet Jill
|
Chief Medical Officer |
Neutral |
90.0
|
+28,515
|
21.12%
|
✗
|
- |
| Feb 1, 2024 |
Feb 2, 2024 |
Feder Julie B
|
CFO |
Neutral |
90.0
|
+71,285
|
113.17%
|
✗
|
- |
| Feb 1, 2024 |
Feb 2, 2024 |
de los Pinos Elisabet
|
Officer |
Neutral |
90.0
|
+162,935
|
55.64%
|
✗
|
- |
| Jan 23, 2024 |
Jan 24, 2024 |
de los Pinos Elisabet
|
Officer |
Sell |
42.5
|
-15,853
|
-5.14%
|
✗
|
$121.1K |
| Jan 23, 2024 |
Jan 24, 2024 |
Feder Julie B
|
CFO |
Sell |
42.5
|
-6,609
|
-9.50%
|
✗
|
$50.5K |
| Nov 7, 2023 |
Nov 9, 2023 |
Johnson David Michael
|
Director |
Buy |
100.0
|
+199,601
|
56.11%
|
✗
|
$1.4M |
| Nov 9, 2023 |
Nov 9, 2023 |
Matrix Capital Management Company, LP
|
10% Owner |
Buy |
100.0
|
+1,560,000
|
29.09%
|
✗
|
$14M |
| Nov 6, 2023 |
Nov 7, 2023 |
de los Pinos Elisabet
|
Officer |
Sell |
41.3
|
-7,449
|
-2.36%
|
✓
|
$89.6K |
| Nov 6, 2023 |
Nov 7, 2023 |
Feder Julie B
|
CFO |
Sell |
36.3
|
-3,900
|
-5.31%
|
✓
|
$47.1K |
| Nov 1, 2023 |
Nov 3, 2023 |
Hopkins Janet Jill
|
Chief Medical Officer |
Neutral |
90.0
|
+135,000
|
100.00%
|
✗
|
- |
| Oct 30, 2023 |
Nov 1, 2023 |
Feder Julie B
|
CFO |
Sell |
46.3
|
-3,385
|
-4.64%
|
✗
|
$23.1K |
| Oct 30, 2023 |
Nov 1, 2023 |
de los Pinos Elisabet
|
Officer |
Sell |
42.5
|
-9,586
|
-2.98%
|
✗
|
$65.5K |
|
Oct 23, 2023 |
Hopkins Janet Jill
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 3, 2023 |
Oct 5, 2023 |
Johnson David Michael
|
Director |
Buy |
90.0
|
+20,066
|
9.76%
|
✗
|
$168.2K |
| Jun 7, 2023 |
Jun 9, 2023 |
Mattessich Antony C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 7, 2023 |
Jun 9, 2023 |
Johnson David Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 7, 2023 |
Jun 9, 2023 |
PAREKH RAJESH B
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 7, 2023 |
Jun 9, 2023 |
Srivastava Sapna
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 19, 2023 |
Jan 23, 2023 |
Feder Julie B
|
CFO |
Neutral |
90.0
|
+48,750
|
201.16%
|
✗
|
- |
| Jan 19, 2023 |
Jan 23, 2023 |
De Rosch Mark
|
COO |
Neutral |
90.0
|
+42,250
|
257.86%
|
✗
|
- |
| Jan 19, 2023 |
Jan 23, 2023 |
de los Pinos Elisabet
|
Officer |
Neutral |
90.0
|
+121,875
|
60.92%
|
✗
|
- |
| Jan 19, 2023 |
Jan 23, 2023 |
Rich Cadmus
|
Officer |
Neutral |
90.0
|
+34,125
|
138.84%
|
✗
|
- |
| Jan 5, 2023 |
Jan 9, 2023 |
Johnson David Michael
|
Director |
Buy |
86.3
|
+2,000
|
5.88%
|
✗
|
$20.8K |
| Dec 28, 2022 |
Dec 30, 2022 |
Johnson David Michael
|
Director |
Buy |
91.3
|
+4,000
|
13.33%
|
✗
|
$39K |
| Dec 1, 2022 |
Dec 15, 2022 |
Johnson David Michael
|
Director |
Buy |
95.0
|
+10,000
|
50.00%
|
✗
|
$123.7K |
| Dec 5, 2022 |
Dec 7, 2022 |
Matrix Capital Management Company, LP
|
10% Owner |
Buy |
100.0
|
+1,250,000
|
30.39%
|
✗
|
$15M |
| Oct 31, 2022 |
Nov 2, 2022 |
Feder Julie B
|
CFO |
Sell |
32.5
|
-2,015
|
-7.68%
|
✓
|
$25.1K |
| Oct 31, 2022 |
Nov 2, 2022 |
Rich Cadmus
|
Officer |
Sell |
36.3
|
-1,672
|
-6.37%
|
✓
|
$20.8K |
| Oct 31, 2022 |
Nov 2, 2022 |
de los Pinos Elisabet
|
Officer |
Sell |
41.3
|
-5,706
|
-2.77%
|
✓
|
$71.1K |
| Oct 31, 2022 |
Nov 2, 2022 |
De Rosch Mark
|
COO |
Sell |
36.3
|
-1,115
|
-6.37%
|
✓
|
$13.9K |
| Jun 15, 2022 |
Jun 17, 2022 |
PAREKH RAJESH B
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
Johnson David Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
Srivastava Sapna
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
Mattessich Antony C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2022 |
Jun 14, 2022 |
Johnson David Michael
|
Director |
Buy |
97.5
|
+50,000
|
100.00%
|
✗
|
$716.3K |
| Nov 2, 2021 |
Nov 4, 2021 |
Medicxi Ventures Management (Jersey) Ltd
|
10% Owner |
Buy |
100.0
|
+710,000
|
30.47%
|
✗
|
$9.9M |
| Nov 2, 2021 |
Nov 4, 2021 |
Matrix Capital Management Company, LP
|
10% Owner |
Buy |
100.0
|
+1,785,000
|
76.68%
|
✗
|
$25M |
| Nov 2, 2021 |
Nov 2, 2021 |
de los Pinos Elisabet
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 2, 2021 |
Nov 2, 2021 |
Johnson David Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 28, 2021 |
Oct 29, 2021 |
Johnson David Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 28, 2021 |
Oct 29, 2021 |
Rich Cadmus
|
Officer |
Neutral |
90.0
|
+26,250
|
100.00%
|
✗
|
- |
| Oct 28, 2021 |
Oct 29, 2021 |
de los Pinos Elisabet
|
Officer |
Neutral |
90.0
|
+74,357
|
58.61%
|
✗
|
- |
| Oct 28, 2021 |
Oct 29, 2021 |
De Rosch Mark
|
COO |
Neutral |
90.0
|
+17,500
|
100.00%
|
✗
|
- |
| Oct 28, 2021 |
Oct 29, 2021 |
Mattessich Antony C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 28, 2021 |
Oct 29, 2021 |
Feder Julie B
|
CFO |
Neutral |
90.0
|
+26,250
|
100.00%
|
✗
|
- |